MR

Mundangattil Rahul Raju

Active Director Director DIN 10409091
DIN 10409091 First appointment Nov 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Mundangattil Rahul Raju

Data last updated:

Mundangattil Rahul Raju is a Director at Grl Pharma Private Limited (since 2023). The company operates in Pharma. Grl Pharma Private Limited reported revenue of ₹2.09 Cr (FY 2025).

DIN 10409091
Primary Designation Director
Industry Pharma
First Appointment 30 Nov 2023
Oldest Company Age 3 yrs
Largest company Grl Pharma Private Limited · ₹2.09 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Grl Pharma Private Limited U46497KL2023PTC084158
Director30 Nov 20232023₹2.09 Cr (FY 2025)Active

Board colleagues of Mundangattil Rahul Raju

Directorship timeline

Open interactive timeline →
Grl Pharma Private Limited
Premium access

Shareholding and investment profile for Mundangattil Rahul Raju

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mundangattil Rahul Raju

Mundangattil Rahul Raju currently holds 1 directorship: Grl Pharma Private Limited (Director, since 30 Nov 2023, revenue ₹2.09 Cr (FY 2025)).

Mundangattil Rahul Raju was first appointed on 30 Nov 2023 as Director at Grl Pharma Private Limited.

The current boards of Mundangattil Rahul Raju's companies include Binu Kozhimannil Mathew (Grl Pharma Private Limited), Chandrasekharan Hemalatha Anush (Grl Pharma Private Limited), Mangalam Krishnan Sachidanandan (Grl Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available